From LABIOTECH.eu by Jonathan Smith
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?
DNA and RNA sequencing technology has undergone a revolution in the last decade, with companies working to provide ever cheaper and faster ways to explore our genetics.
This stride forward in sequencing has, in turn, led to the development of personalized medicines to treat a range of diseases such as cancer. For example, physicians can plan the most appropriate immunotherapy for a patient based on DNA and messenger (m)RNA extracted and sequenced from a tumor sample.
However, this sequencing approach has its limits…READ MORE